2 Indian drugmakers seek approval for COVID-19 vaccines

Move follows Pfizer application, with first licensing possible in a few weeks

20201208N Temperature check

Passengers wait in line to have their temperature checked at a railway station in Mumbai on Nov. 26. © Reuters

KIRAN SHARMA, Nikkei staff writer

NEW DELHI -- Two Indian companies have applied for emergency approval of their COVID-19 vaccine candidates in a country that is the second-worst hit by the coronavirus pandemic, days after U.S. drugmaker Pfizer did the same.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.